Cullinan Oncology LLC

NASDAQ CGEM

Data sourced from iex and EODHD
Download Data

Cullinan Oncology LLC Income Statement 2012 - 2024

This table shows the Income Statement for Cullinan Oncology LLC going from 2012 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31
Revenue
M 0 0 0 0 0 0 0 0 0 -38 0 0 19 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - -
Cost of Revenue
M 0 0 0 0 0 0 - - - - - - - - - - - - 0 0 0 0 0 0 - - - - - - - - - - - - - -
Gross Profit
M 0 0 0 0 0 0 - - - -38 - - 19 - - - - - 0 0 0 0 0 0 - - - - - - - - - - - - - -
Operating Expenses
M 43 45 45 38 63 33 - - - -4 - - 18 - - - - - 0 0 0 0 0 0 - - - - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 12 11 11 10 11 11 10 11 8 13 6 5 5 13 2 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Research and Development (R&D) Expenses
M 31 35 34 27 52 21 20 26 25 21 13 12 12 17 10 12 4 4 - - - - - - - - - - - - - - - - - - - -
Other Operating Expenses
M 0 0 0 0 0 0 - - - -38 - - 0 - - - - - - - - - - - - - - - - - - - - - - - - -
Costs and Expenses
M 43 45 45 38 63 33 - - - - - - - - - - - - 0 0 0 0 0 0 - - - - - - - - - - - - - -
Operating Income
M -43 -45 -45 -38 -63 -33 -30 240 -33 -34 -18 -17 1 -29 -11 -14 -6 -5 0 0 0 0 0 0 - - - - - - - - - - - - - -
Interest Expense
M - - - - -5 -3 2 1 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - -
Non-operating Income/Expense
M 6 6 0 0 5 4 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - -
EBT
M -37 -40 -39 -32 -58 -29 -27 240 -32 -34 -18 -16 1 -29 -11 -14 -5 -5 0 0 0 0 0 0 - - - - - - - - - - - - - -
Income Tax Provision
M 0 -14 -5 -5 0 -2 -3 66 -20 0 -1 -1 1 7 -1 -5 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - -
Income after Tax
M -37 -26 -34 -27 -58 -27 -25 174 -13 -34 -17 -15 0 -36 -10 -8 -5 -5 0 0 0 0 0 0 - - - - - - - - - - - - - -
Non-Controlling Interest
M - - - 0 0 0 0 -1 -1 0 0 -1 1 -1 -1 -7 0 - 0 0 0 0 0 0 - - - - - - - - - - - - - -
Net Income
M - - - -32 -58 -27 -25 175 -12 -33 -17 -16 0 -28 -10 -7 -5 - 0 0 0 0 0 0 - - - - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 43,011,000.00 42,794,000.00 42,734,000.00 39,952,000.00 40,682,000.00 45,751,000.00 45,611,000.00 46,381,000.00 44,431,657.00 43,643,397.00 43,439,000.00 43,295,000.00 41,977,336.00 41,977,336.00 37,831,237.00 19,361,467.00 19,361,467.00 19,361,467.00 - - - - - - - - - - - - - - - - - - - -
EBITDA
M -43 -45 -44 -38 -63 -33 -30 -314 -33 -34 -18 -17 1 -29 -11 -14 -6 -5 - - - - - - - - - - - - - - - - - - - -
Depreciation and Amortization
M 0 0 0 0 0 0 0 -554 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - -
EBIT
M -43 -45 -44 -38 -63 -33 -30 240 -33 -34 -18 -17 1 -29 -11 -14 -6 -5 0 0 0 0 0 0 - - - - - - - - - - - - - -
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 0.51 35.59 13.88 16.77 0.31 6.42 9.20 27.51 60.28 -0.65 5.62 5.94 100.42 -23.70 12.87 39.63 3.68 3.42 0.00 0.00 0.00 0.00 0.00 0.00 - - - - - - - - - - - - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - -
Gross Profit Margin
% - - - - - - - - - 100.00 - - 100.00 - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Income Margin
% - - - - - - - - - 90.75 - - 7.24 - - - - - - - - - - - - - - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - 85.91 - - -0.37 - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% - - - - - - - - - 90.75 - - 7.24 - - - - - - - - - - - - - - - - - - - - - - - - -
EBIT Ratio
% - - - - - - - - - 90.78 - - 7.16 - - - - - - - - - - - - - - - - - - - - - - - - -
EBT Ratio
% - - - - - - - - - 90.37 - - 7.49 - - - - - - - - - - - - - - - - - - - - - - - - -

StockViz Staff

September 8, 2024

Any question? Send us an email